Houston Chronicle Features Dr. James Martin’s Congenital Heart Disease Research
Congenital heart disease (CHD) – a spectrum of heart defects that develop before birth – can lead to pediatric heart...
Congenital heart disease (CHD) – a spectrum of heart defects that develop before birth – can lead to pediatric heart...
THI’s Cardiomyocyte Renewal Laboratory takes a closer look at the gene expression landscape of congenital heart disease Researchers in the...
Scientists Develop a Roadmap to Future Personalized Medicine for Heart Defects that Develop Before Birth HOUSTON, TX – (June...
Texas Heart Institute’s Rich Gang Li, PhD, recently earned the award for “Best Oral Presentation” for his platform talk at...
The impact of a scientific article is often described in terms of how many times the article has been cited...
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
The New Paper Follows Closely on the Heels of a Related Publication on Cardiomyocyte Renewal Following a Heart Attack ...
Patients suffering from heart failure have very limited treatment options, and up to this point, it had essentially been impossible...
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
More than 450 children undergo a heart transplant in the United States each year. Despite incredible advances in the field...
Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...
Texas Heart Institute has been at the forefront of cardiovascular discovery and innovation since its formation. It continues to relentlessly...